Fact CheckerSign in

NCT06785376Recruiting

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention

Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual and Same-gender Loving Men

Source: ClinicalTrials.gov · Last updated 31 Aug 2026

Brief summary (registry, in English)

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
480 (estimated)
First submitted
16 Jan 2025
Start date
19 Dec 2024
Primary completion date
28 Feb 2028
Lead sponsor
Columbia University
Diseases
HIV
NCT number
NCT06785376

What you commit to

  • Study type: Interventional
  • Planned participants: 480
  • From 19 Dec 2024 to the primary completion date, 28 Feb 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Unable to conduct a rapid HIV-self test to confirm self-reported HIV-negative status

Who the study is looking for

  • Assigned biological male sex at birth
  • 18-65 years of age
  • Self-identify as: Black, African-American, Afro-Caribbean, Black African, Afro-Latino or multiethnic Black
  • Reside in the NYC metro area
  • Not HIV-positive (tested before randomization)
  • Report insertive or receptive anal intercourse with another man in the past six months
  • Not currently on PEP or PrEP
  • Can communicate in English or Spanish
  • Provide informed consent for the study
  • Any sexual identity

Age in the registry: 18 years to 65 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Columbia University
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.